Federal drug safety regulators have recommended pausing the use of Johnson & Johnson’s COVID-19 vaccine after six women experienced blood clots after vaccination.
Of the six women who experienced clots, one died and another is hospitalized.
Experts are still investigating whether the vaccine was the cause of these events.
